Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-31
1989-10-24
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514401, 548317, 548322, 548351, A61K 31415, C07D23342
Patent
active
048762660
ABSTRACT:
Disclosed are novel substituted 3-aralkylimidazolines of the structure. ##STR1## processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy in particular as dopamine-.beta.-hydroxylase inhibitors.
REFERENCES:
patent: 3488423 (1970-01-01), Doebel et al.
patent: 3915980 (1975-10-01), Gebert et al.
patent: 4532331 (1985-07-01), Frazee et al.
Chemical Abstracts, 105:15302k (1986) [Jpn. Kokai G104,038, Kaneko et al., 1/9/86].
Chemical Abstracts, 94:192224m (1981) [Markov, V., et al., Vopr. Khim. Khim. Tekhnol, 59, 55 (1980)].
Chemical Abstracts, 89:107125j (1978) [Bovin-Roubaud, et al., C. R. Hebd. Seances Acad. Sci., Ser. C 1978, 286(20) 521-4].
Chemical Abstracts, 86:42591z (1977) [Assef, et al., C. R. Hebd. Seances Acad. Sci., Ser. C 1976, 282(11), 485-6].
Chemical Abstracts, 78:136299x (1973) [Ger. Offen. 2,140,405, Hiltmann et al., 2/22/73].
Chemical Abstracts, 64:15864e (1966) [Cherbuliez et al., Helv. Chim. Acta 49(1), 807-31 (1966)].
P. Iversen, et al., Acta Chem. Scand., 21:279-285 (1967).
R. Fuller, et al., Adv. Enzyme Regul., 15:267-281 (1976).
Chemical Abstracts, 72:39275e (1970) [Gebert et al., Hoppe-Seyler's Z. Physiol. Chem. 1969, 360(11), 1327-30].
J. Bream, et al., Helv. Chim. Acta, 60:2872-2880 (1977).
Kruse Lawrence I.
Leonard Thomas B.
Ross Stephen T.
Lourie Alan D.
McCarthy Mary E.
Schwartz Richard A.
SmithKline Beckman Corporation
Suter Stuart R.
LandOfFree
1-aralkyl-2-mercaptoimidazolines as DBH inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-aralkyl-2-mercaptoimidazolines as DBH inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1589482